Clinical research and studies demonstrate Gondola AMPS therapy’s effectiveness for people with neurological disease to move better and live better. The CHF 500’000 Tech Growth loan from the Fondation pour l’Innovation Technologique (FIT), supports Gondola Medical Technologies to develop their clinical research capabilities further. From start-up to scale-up Gondola Medical Technologies is a Swiss MedTech
Dr. F. Cecchini (Gondola SA): As a startup, Research & Development (R&D) funding is crucial and a strategy to meet this need must be designed in advance. In addition to the numerous grant opportunities available in Switzerland (start-up bids, foundations supporting innovative ideas, etc...), Innosuisse (the Swiss Innovation Agency) provides support for startup businesses.
Gondola Medical Technologies SA, a Swiss company specialising in restorative therapies for neurologic conditions, has completed a strategic round of funding for the development of two new products to be launched in the market in Q2 2020. The GONDOLA medical device is a proprietary device to give AMPS treatment (Automated Mechanical Peripheral Stimulation) for
Il progetto di Francesco Cecchini si è aggiudicato il successo alla manifestazione che premia l'innovazione ticinese. LUGANO - È la start-up Ecker Technologies con il progetto Gondola®, presentato da Francesco Cecchini, che grazie al voto della Giuria e a quello del pubblico presente in sala, rivelatosi decisivo, si è aggiudicata il premio da 50'000
